ARCA Biopharma Inc
NASDAQ:ABIO
ARCA Biopharma Inc
NASDAQ:ABIO
Price:
2.4
USD
-4%
Market Closed
Market Cap:
$10.9B
Balance Sheet
Balance Sheet Decomposition
ARCA Biopharma Inc
ARCA Biopharma Inc
Balance Sheet Decomposition is not available for
ARCA Biopharma Inc
ARCA Biopharma Inc
Balance Sheet
ARCA Biopharma Inc
ARCA Biopharma Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
15
|
39
|
7
|
9
|
7
|
8
|
49
|
53
|
42
|
37
|
|
| Cash Equivalents |
15
|
39
|
7
|
9
|
7
|
8
|
49
|
53
|
42
|
37
|
|
| Short-Term Investments |
0
|
0
|
14
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
16
|
39
|
21
|
12
|
7
|
9
|
50
|
54
|
43
|
38
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
16
N/A
|
40
+146%
|
25
-38%
|
12
-50%
|
7
-45%
|
9
+25%
|
50
+493%
|
55
+9%
|
43
-22%
|
38
-12%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
0
|
0
|
2
|
1
|
0
|
0
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
2
|
2
|
1
|
1
|
4
|
3
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+7%
|
2
+60%
|
2
-13%
|
1
-62%
|
1
+13%
|
4
+333%
|
4
0%
|
1
-64%
|
1
-40%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
85
|
96
|
113
|
131
|
139
|
144
|
154
|
173
|
183
|
189
|
|
| Additional Paid In Capital |
99
|
134
|
135
|
141
|
145
|
152
|
201
|
225
|
225
|
226
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
15
N/A
|
38
+159%
|
22
-42%
|
10
-54%
|
6
-42%
|
8
+27%
|
47
+512%
|
51
+10%
|
42
-18%
|
37
-11%
|
|
| Total Liabilities & Equity |
16
N/A
|
40
+146%
|
25
-38%
|
12
-50%
|
7
-45%
|
9
+25%
|
50
+493%
|
55
+9%
|
43
-22%
|
38
-12%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
1
|
1
|
1
|
1
|
2
|
10
|
14
|
14
|
15
|
|
Switch to:
Switch to:
See Also
Discover More
